Brenda started her FDA career as a CMC reviewer in CDER focusing on sterility assurance and the microbiological aspect of NDA, ANDA and BLA submissions.

• 她以CDER的CMC检查员职务开始了在FDA的职业生涯，关注无菌保障及NDA,ANDA以及BLA提交的微生物案例等。